Page 115 - The COVID-19 Chronicles of Malaysia: The Tsunami

COVID-19 Vaccines

2 Mar 2021: Conditional Product
Registration The 354th Drug Control
Authority Meeting approves the
conditional registration for use during a
disaster for the following:
COVID-19 Vaccine AstraZeneca
Solution for Injection

CoronaVac Suspension for Injection -
Sinovac
COMIRNATY Concentrate for
Dispersion for Injection (Application for Source: Bernama TV YouTube §
second source to COMIRNATY products
that have been given conditional
registration)
Companies to submit analysis of
additional and up-to-date data by rolling
submission to be evaluated by the
National Pharmaceutical Regulatory
Division (NPRA) to ensure updated

vaccine effectiveness and safety of
profile, and benefits over risk of vaccine
Source: Buletin TV3 YouTube §
remains positive.

NPRA is currently evaluating:
Gam-COVID-Vac or Sputnik V (by
Gamaleya National Research Center for
Epidemiology and Microbiology,
Russia) and
CoronaVac Suspension for Injection -

Sinovac (manufacture of fill & finish by
Pharmaniaga LifeScience Sdn Bhd). §
2 Mar 2021: Private Vaccination Centres
Private hospitals are vaccination centres
for private healthcare workers (HCW) for

phase one. § § § Source: Buletin TV3 YouTube §
72